Search Result "IFN-1a"
Characterization of Regulatory T-Cells in Multiple Sclerosis Patients Treated with Interferon Beta-1a
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 17 Issue: 2 Year: 2018 Page: 113-118
Author(s): Mohsen Ebrahimimonfared,Ali Ganji,Sara Zahedi,Parisa Nourbakhsh,Keyvan Ghasami,Ghasem Mosayebi
Cytokines as Novel Therapeutic Agents for Neuroinflammatory Disorders: A Role for Interferon-β in the Treatment of Multiple Sclerosis
Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 1 Issue: 3 Year: 2001 Page: 201-208
Author(s): Moiz Bakhiet
Assessment of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-Beta1 Serum Titers in Relapsing Remitting Multiple Sclerosis Patients Treated with Avonex, Possible Biomarkers for Treatment Response
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 1 Year: 2017 Page: 93-101
Author(s): Rodica Balasa,Smaranda Maier,Septimiu Voidazan,Adina Hutanu,Zoltan Bajko,Anca Motataianu,Brandusa Tilea,Cristina Tiu
Interferon-Beta Injection in Multiple Sclerosis Patients Related to the Inductionof Headache and Flu-Like Pain Symptoms: A Systematic Reviewand Meta-Analysis of Randomised Controlled Trials
Journal: Current Neuropharmacology
Volume: 20 Issue: 8 Year: 2022 Page: 1600-1612
Author(s): LuÃs Guilherme Ramanzini,Julia Maria Frare,Fernanda Tibolla Viero,Leonardo Gomes Pereira
Therapy of Chronic Hepatitis C: A Critical Review
Journal: Current Drug Targets - Infectious Disorders
Volume: 3 Issue: 1 Year: 2003 Page: 25-32
Author(s): G. Saracco, A. Olivero, A. Ciancio, S. Carenzi, M. Rizzetto
Aligned Expression of IFI16 and STING Genes in RRMS Patientsâ Blood
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 20 Issue: 6 Year: 2020 Page: 878-886
Author(s): Sobhan Helbi,Behnam Ravanbakhsh,Mohammad Karimi,Wesam Kooti,Nahid Jivad
Deciphering the Significance of Plasma Chemokines as PrognosticBiomarkers in Pegylated IFN-Î-2a /Ribavirin-Treated Chronic HepatitisC Genotype 4 Patients
Journal: Infectious Disorders - Drug Targets
Volume: 22 Issue: 5 Year: 2022 Page: 58-62
Author(s): M. Haroon Hamed,Peter Natesan Pushparaj
Gut Inflammation: Current Update on Pathophysiology, Molecular Mechanism and Pharmacological Treatment Modalities
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 7 Year: 2014 Page: 1063-1081
Author(s): Klara Gyires, Eva Viktoria Toth, Sandor Zoltan Zadori
Drugs Used in the Treatment of Multiple Sclerosis During COVID-19Pandemic: A Critical Viewpoint
Journal: Current Neuropharmacology
Volume: 20 Issue: 1 Year: 2022 Page: 107-125
Author(s): Marco Salvetti,Ruggero Capra,Ferdinando Nicoletti,Chiara Calderoni,Antonietta Gentile,Gianmarco Bellucci,Marika Alborghetti
Advances in Antioxidative Therapy of Multiple Sclerosis
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 37 Year: 2013 Page: 4720-4730
Author(s): E. Miller,B. Wachowicz